Synthesis and Characterization of Piperic Acid Conjugates with Homochiral and Heterochiral Dipeptides Containing Phenylalanine and Their Application in Skin Cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and Characterization of Piperic Acid Conjugates with Homochiral and Heterochiral Dipeptides Containing Phenylalanine and Their Application in Skin Cancer
Authors
Keywords
-
Journal
PEPTIDES
Volume -, Issue -, Pages 171113
Publisher
Elsevier BV
Online
2023-11-04
DOI
10.1016/j.peptides.2023.171113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heterochiral dipeptide d ‐phenylalanyl‐ l ‐phenylalanine (H‐ D Phe‐ L Phe‐OH) as a potential inducer of metastatic suppressor NM23H1 in p53 wild‐type and mutant cells
- (2022) Mir Mohd Faheem et al. MOLECULAR CARCINOGENESIS
- STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway
- (2021) Alexander Swoboda et al. ONCOGENE
- Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation
- (2021) Jinyun Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- The role of JAK/STAT signaling pathway and its inhibitors in diseases
- (2020) Ping Xin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Epidemiology of Skin Cancer and Public Health Strategies for Its Prevention in Southern Africa
- (2020) Caradee Y. Wright et al. International Journal of Environmental Research and Public Health
- Indolylkojyl methane analogue IKM5 potentially inhibits invasion of breast cancer cells via attenuation of GRP78
- (2019) Debasis Nayak et al. BREAST CANCER RESEARCH AND TREATMENT
- Cytokines in Inflammatory Disease
- (2019) Shinwan Kany et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activated Stat-3 in Melanoma
- (2017) Jane L. Messina et al. Cancer Control
- Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma
- (2016) Hui-Hui Cao et al. Scientific Reports
- Inhibition of Invasion in Pancreatic Cancer Cells by Conjugate of EPA with β3,3-Pip-OH via PI3K/Akt/NF-kB Pathway
- (2015) Hina Amin et al. ACS Medicinal Chemistry Letters
- Caffeic acid attenuates the autocrine IL-6 in hepatocellular carcinoma via the epigenetic silencing of the NF-κB-IL-6-STAT-3 feedback loop
- (2015) Lingling Wang et al. RSC Advances
- CancerPPD: a database of anticancer peptides and proteins
- (2014) Atul Tyagi et al. NUCLEIC ACIDS RESEARCH
- STAT3 Target Genes Relevant to Human Cancers
- (2014) Richard Carpenter et al. Cancers
- Inflammatory cytokines in human pancreatic cancer
- (2013) Rozita Roshani et al. CANCER LETTERS
- Improving Binding Affinity and Stability of Peptide Ligands by Substituting Glycines withD-Amino Acids
- (2013) Shiyu Chen et al. CHEMBIOCHEM
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular Pathways Linking Inflammation and Cancer
- (2010) A. Mantovani CURRENT MOLECULAR MEDICINE
- Synthesis of piperine–amino acid ester conjugates and study of their cytotoxic activities against human cancer cell lines
- (2010) V. Rama Subba Rao et al. MEDICINAL CHEMISTRY RESEARCH
- Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer
- (2009) Bharat B. Aggarwal et al. Annals of the New York Academy of Sciences
- Solar ultraviolet radiation and skin cancer
- (2009) C. Young OCCUPATIONAL MEDICINE-OXFORD
- Pathways connecting inflammation and cancer
- (2008) Paola Allavena et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Cancer is a Preventable Disease that Requires Major Lifestyle Changes
- (2008) Preetha Anand et al. PHARMACEUTICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now